Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Jorge A. Garcia, MD, Department of Hematology and Oncology, Cleveland Clinic, discusses some of the challenges with immunotherapy in prostate cancer.

Dr. Garcia on Challenges With Immunotherapy in Prostate Cancer

Richard W. Joseph, MD, Department of Hematology/Oncology, Mayo Clinic, discusses some improvements needed in the field of immunotherapy as a treatment for melanoma.

Dr. Joseph on Necessary Improvements on Immunotherapy in Melanoma

Treatment with the immunotherapy Vigil delayed time to progression in all patients with stage III/IV ovarian cancer who were treated with the autologous tumor cell vaccine compared with those who were not in an open-label phase II trial.

Autologous Vaccine Delays Progression Following Surgery for Ovarian Cancer

Jedd Wolchok, MD, PhD, chief, of Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses the toxicities associated with immunotherapy.

Dr. Jedd Wolchok on Immunotherapy Toxicities

Novel Therapies Needed for Muscle-Invasive Bladder Cancer

Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

Potential Targets in Muscle-Invasive Bladder Cancer

Treating Relapsed Muscle-Invasive Bladder Cancer

Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

Neoadjuvant and Adjuvant Therapy in Bladder Cancer

Managing Renal Pelvis Transitional Cell Carcinoma

Lymph Node Dissection in Bladder Cancer

Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System, discusses immunotherapy for cancer treatment.

Immuno-Oncology | Specialty